{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:50:48Z","timestamp":1791820248073,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["#202108440067"],"award-info":[{"award-number":["#202108440067"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health and Medical Research Council","award":["#2016909"],"award-info":[{"award-number":["#2016909"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["L2, #2025894"],"award-info":[{"award-number":["L2, #2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the demographic and clinical characteristics of patients attending pain management services who were receiving opioid agonist treatment (ie, methadone or buprenorphine for the treatment of opioid use disorder) in comparison with those taking prescription opioid analgesics in oral morphine equivalent daily doses at low (&amp;lt;40\u2009mg) and high doses (&amp;gt;100\u2009mg) in a national database from the electronic Persistent Pain Outcomes Collaboration (ePPOC) in Australia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A cross-sectional study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Australian pain services.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>Adult patients referred to Australian pain service clinics between 2016 and 2021.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Multinomial and bivariate logistic regression models were conducted to compare the demographic and clinical characteristics of patients on opioid agonist treatment and those taking other prescription opioid analgesics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 42\u200a182 participants, most were female (56.8%), with a mean age of 51.7\u2009years. People on opioid agonist treatment (n\u2009=\u20091016) and high-dose opioids (n\u2009=\u20097122) were similar in that they both had more severe mental health symptoms and longer pain duration than the low-dose group (n\u2009=\u200920\u200a517). Compared with the high-dose group, people on opioid agonist treatment had reduced odds of reporting more severe pain intensity but increased odds of having multimorbidity, more severe anxiety, and pain catastrophizing thoughts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings highlight the need for mental health treatment and the necessity of tailored multidisciplinary pain management for people in opioid agonist treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnaf011","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T16:06:16Z","timestamp":1739376376000},"page":"237-247","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9547-7298","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"first","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria 3199,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7839-6058","authenticated-orcid":false,"given":"Melita","family":"Giummarra","sequence":"additional","affiliation":[{"name":"Caulfield Pain Management and Research Centre, Caulfield Hospital , Melbourne, Victoria 3162,","place":["Australia"]},{"name":"Department of Neuroscience, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria 3004,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3209","authenticated-orcid":false,"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria 3199,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Arnold","sequence":"additional","affiliation":[{"name":"Caulfield Pain Management and Research Centre, Caulfield Hospital , Melbourne, Victoria 3162,","place":["Australia"]},{"name":"Department of Anaesthesia and Perioperative Medicine, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria 3004,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria 3199,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"issue":"4","key":"2025050203520650600_pnaf011-B1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1037\/0033-2909.133.4.581","article-title":"The biopsychosocial approach to chronic pain: scientific advances and future directions","volume":"133","author":"Gatchel","year":"2007","journal-title":"Psychol Bull"},{"issue":"6","key":"2025050203520650600_pnaf011-B2","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","article-title":"Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"GBD 2021 Low Back Pain Collaborators","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"2025050203520650600_pnaf011-B3","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/j.pain.0000000000001009","article-title":"Defining chronic pain in epidemiological studies: a systematic review and meta-analysis","volume":"158","author":"Steingr\u00edmsd\u00f3ttir","year":"2017","journal-title":"Pain"},{"key":"2025050203520650600_pnaf011-B4","author":"Australian Institute of Health and Welfare","year":"2020"},{"issue":"11","key":"2025050203520650600_pnaf011-B5","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/add.16574","article-title":"Pain in people seeking and receiving opioid agonist treatment: a systematic review and meta-analysis of prevalence and correlates","volume":"119","author":"Yang","year":"2024","journal-title":"Addiction"},{"issue":"4","key":"2025050203520650600_pnaf011-B6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00043764-196604000-00028","article-title":"A medical treatment for diacetylmorphine (heroin) addiction","volume":"8","author":"Dole","year":"1966","journal-title":"J Occup Environ Med"},{"key":"2025050203520650600_pnaf011-B7","author":"Healthdirect","year":"2023"},{"key":"2025050203520650600_pnaf011-B8","doi-asserted-by":"publisher","first-page":"104255","DOI":"10.1016\/j.drugpo.2023.104255","article-title":"Trends in use of medicines for opioid agonist treatment in Australia, 2013\u20132022","volume":"123","author":"Bharat","year":"2024","journal-title":"Int J Drug Policy"},{"key":"2025050203520650600_pnaf011-B9","doi-asserted-by":"publisher","first-page":"641430","DOI":"10.3389\/fpsyt.2021.641430","article-title":"Prevalence and characteristics of chronic pain in buprenorphine and methadone-maintained patients","volume":"12","author":"Delorme","year":"2021","journal-title":"Front Psychiatry"},{"issue":"9","key":"2025050203520650600_pnaf011-B10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/pme.12773","article-title":"Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the Pain and Opioids in Treatment (POINT) cohort","volume":"16","author":"Campbell","year":"2015","journal-title":"Pain Med"},{"key":"2025050203520650600_pnaf011-B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/SART.S30120","article-title":"Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis","volume":"9","author":"Dennis","year":"2015","journal-title":"Subst Abuse"},{"issue":"2","key":"2025050203520650600_pnaf011-B12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"2025050203520650600_pnaf011-B13","doi-asserted-by":"publisher","first-page":"e0176288","DOI":"10.1371\/journal.pone.0176288","article-title":"Pain in methadone patients: Time to address undertreatment and suicide risk (ANRSMethaville trial)","volume":"12","author":"Nordmann","year":"2017","journal-title":"PLoS One"},{"issue":"16","key":"2025050203520650600_pnaf011-B14","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1080\/14656566.2019.1652270","article-title":"Pain management in opioid maintenance treatment","volume":"20","author":"Koller","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2025050203520650600_pnaf011-B15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpain.2020.10.005","article-title":"Assessment of chronic pain management in the treatment of opioid use disorder: gaps in care and implications for treatment outcomes","volume":"22","author":"Ellis","year":"2021","journal-title":"J Pain"},{"issue":"1","key":"2025050203520650600_pnaf011-B16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpain.2010.04.009","article-title":"The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment","volume":"12","author":"Peles","year":"2011","journal-title":"J Pain"},{"issue":"3","key":"2025050203520650600_pnaf011-B17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pain.2004.11.011","article-title":"Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain","volume":"113","author":"Peles","year":"2005","journal-title":"Pain"},{"issue":"4","key":"2025050203520650600_pnaf011-B18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmjspcare-2016-001126","article-title":"Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature","volume":"7","author":"Taveros","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"2025050203520650600_pnaf011-B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/ajad.12859","article-title":"No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: a 3-month randomized study and 9-month open-treatment follow-up study","volume":"28","author":"Latif","year":"2019","journal-title":"Am J Addict"},{"issue":"6","key":"2025050203520650600_pnaf011-B20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/pm\/pnw201","article-title":"Establishment of the Australasian electronic Persistent Pain Outcomes Collaboration","volume":"18","author":"Tardif","year":"2017","journal-title":"Pain Med"},{"issue":"11","key":"2025050203520650600_pnaf011-B21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"2025050203520650600_pnaf011-B22","author":"Shebeshi","year":"2022"},{"issue":"9","key":"2025050203520650600_pnaf011-B23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/pm\/pnab011","article-title":"Evaluation of the relationship between geographic proximity and treatment for people referred to a metropolitan multidisciplinary pain clinic","volume":"22","author":"Giummarra","year":"2021","journal-title":"Pain Med"},{"key":"2025050203520650600_pnaf011-B24","author":"Therapeutic Goods Administration","year":"2018"},{"key":"2025050203520650600_pnaf011-B25","author":"Australian Bureau of Statistics","year":"2016"},{"key":"2025050203520650600_pnaf011-B26","author":"The Department of Social Services","year":"2024"},{"key":"2025050203520650600_pnaf011-B27","author":"Australian Bureau of Statistics","year":"2021"},{"issue":"Pt 2","key":"2025050203520650600_pnaf011-B28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1348\/014466505X29657","article-title":"The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample","volume":"44","author":"Henry","year":"2005","journal-title":"Br J Clin Psychol"},{"key":"2025050203520650600_pnaf011-B29","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"issue":"1","key":"2025050203520650600_pnaf011-B30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/1471-2458-14-780","article-title":"Overcoming cut-off restrictions in multimorbidity prevalence estimates","volume":"14","author":"Holzer","year":"2014","journal-title":"BMC Public Health"},{"issue":"5","key":"2025050203520650600_pnaf011-B31","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025050203520650600_pnaf011-B32","volume-title":"The Brief Pain Inventory: User Guide","author":"Cleeland","year":"2009"},{"issue":"2","key":"2025050203520650600_pnaf011-B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","article-title":"The Pain Self-Efficacy Questionnaire: taking pain into account","volume":"11","author":"Nicholas","year":"2007","journal-title":"Eur J Pain"},{"issue":"4","key":"2025050203520650600_pnaf011-B34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/s1836-9553(10)70047-3","article-title":"The Pain Catastrophizing Scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychological Assessment"},{"key":"2025050203520650600_pnaf011-B35","author":"Nicholas","year":"1989"},{"key":"2025050203520650600_pnaf011-B36","author":"Sullivan","year":"2009"},{"issue":"9","key":"2025050203520650600_pnaf011-B37","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/sim.8063","article-title":"Sample size considerations and predictive performance of multinomial logistic prediction models","volume":"38","author":"de Jong","year":"2019","journal-title":"Stat Med"},{"key":"2025050203520650600_pnaf011-B38","author":"College Station","year":"2021"},{"issue":"4","key":"2025050203520650600_pnaf011-B39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"4","key":"2025050203520650600_pnaf011-B40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025050203520650600_pnaf011-B41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fpsyt.2020.00794","article-title":"Prevalence of opioid dependence and opioid agonist treatment in the Berlin custodial setting: a cross-sectional study","volume":"11","author":"von Bernuth","year":"2020","journal-title":"Front Psychiatry"},{"issue":"1","key":"2025050203520650600_pnaf011-B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0885-3924(99)00144-X","article-title":"Characteristics of methadone maintenance patients with chronic pain","volume":"19","author":"Jamison","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"2025050203520650600_pnaf011-B43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.06.024","article-title":"Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy","volume":"166","author":"Tsui","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2025050203520650600_pnaf011-B44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1037\/ser0000607.supp","article-title":"Opioid use disorder with chronic pain increases disease burden and service use","volume":"20","author":"Maclean","year":"2023","journal-title":"Psychol Serv"},{"issue":"6","key":"2025050203520650600_pnaf011-B45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"2025050203520650600_pnaf011-B46","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/jocn.17139","article-title":"The current state of knowledge on care for co-occurring chronic pain and opioid use disorder: a scoping review","volume":"33","author":"Archambault","year":"2024","journal-title":"J Clin Nurs"},{"key":"2025050203520650600_pnaf011-B47","doi-asserted-by":"publisher","first-page":"109097","DOI":"10.1016\/j.drugalcdep.2021.109097","article-title":"Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: a systematic review of experimental pain studies","volume":"228","author":"De Aquino","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2025050203520650600_pnaf011-B48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12875-024-02474-6","article-title":"Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour","volume":"25","author":"Wilson","year":"2024","journal-title":"BMC Prim Care"},{"key":"2025050203520650600_pnaf011-B49","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.ypmed.2019.105852","article-title":"The nexus of opioids, pain, and addiction: challenges and solutions","volume":"128","author":"Henningfield","year":"2019","journal-title":"Prev Med"},{"key":"2025050203520650600_pnaf011-B50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.puhe.2015.11.018","article-title":"Factors associated with the health care cost in older Australian women with arthritis: an application of the Andersen\u2019s Behavioural Model of Health Services Use","volume":"134","author":"Lo","year":"2016","journal-title":"Public Health"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaf011\/61861145\/pnaf011.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/5\/237\/61861145\/pnaf011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/5\/237\/61861145\/pnaf011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:52:16Z","timestamp":1746172336000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/26\/5\/237\/8010470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaf011","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,12]]}}}